Funder: Alzheimer's Association
Due Dates: August 6, 2025 (Letter of Intent) | September 24, 2025 (Full Application, by invitation)
Funding Amounts: Up to $1,000,000 (direct + indirect costs) over 2–3 years; 10% indirect cost cap for non-profits, none for for-profits.
Summary: Supports IND-enabling preclinical development of rigorously characterized, disease-modifying therapeutics for Alzheimer's and related dementias.
Key Information: Open internationally to both academic and small for-profit organizations; postdocs and non-permanent positions are not eligible.